Australia markets closed

IQVIA Holdings Inc. (IQV)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
239.02+0.40 (+0.17%)
As of 01:03PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 43.43B
Enterprise value 55.83B
Trailing P/E 32.73
Forward P/E 21.69
PEG ratio (5-yr expected) 1.36
Price/sales (ttm)2.97
Price/book (mrq)7.11
Enterprise value/revenue 3.73
Enterprise value/EBITDA 17.15

Trading information

Stock price history

Beta (5Y monthly) 1.52
52-week change 325.60%
S&P500 52-week change 325.01%
52-week high 3261.73
52-week low 3167.42
50-day moving average 3244.38
200-day moving average 3220.04

Share statistics

Avg vol (3-month) 3944.21k
Avg vol (10-day) 3758.32k
Shares outstanding 5182.01M
Implied shares outstanding 6182.01M
Float 8179.8M
% held by insiders 10.92%
% held by institutions 192.33%
Shares short (28 Mar 2024) 42.89M
Short ratio (28 Mar 2024) 43.22
Short % of float (28 Mar 2024) 41.82%
Short % of shares outstanding (28 Mar 2024) 41.59%
Shares short (prior month 29 Feb 2024) 42.93M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 9.06%
Operating margin (ttm)13.65%

Management effectiveness

Return on assets (ttm)4.98%
Return on equity (ttm)22.87%

Income statement

Revenue (ttm)14.98B
Revenue per share (ttm)81.52
Quarterly revenue growth (yoy)3.50%
Gross profit (ttm)N/A
EBITDA 2.72B
Net income avi to common (ttm)1.36B
Diluted EPS (ttm)7.30
Quarterly earnings growth (yoy)106.60%

Balance sheet

Total cash (mrq)1.5B
Total cash per share (mrq)8.24
Total debt (mrq)14.28B
Total debt/equity (mrq)233.67%
Current ratio (mrq)0.86
Book value per share (mrq)33.67

Cash flow statement

Operating cash flow (ttm)2.15B
Levered free cash flow (ttm)1.35B